Alzinova AB (ALZ) - Total Liabilities

Latest as of December 2025: Skr21.47 Million SEK ≈ $2.31 Million USD

Based on the latest financial reports, Alzinova AB (ALZ) has total liabilities worth Skr21.47 Million SEK (≈ $2.31 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Alzinova AB - Total Liabilities Trend (2012–2025)

This chart illustrates how Alzinova AB's total liabilities have evolved over time, based on quarterly financial data. See Alzinova AB (ALZ) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Alzinova AB Competitors by Total Liabilities

The table below lists competitors of Alzinova AB ranked by their total liabilities.

Company	Country	Total Liabilities
Cambium Bio Ltd AU:CMB	Australia	AU$1.46 Million
Samyang Corp Preference Shares KO:145995	Korea	₩1.78 Trillion
Target Healthcare REIT Ltd LSE:THRL	UK	GBX236.22 Million
EXCELLENCE S.A. ZY -10 F:8XY	Germany	€10.01 Million
Labrador Gold Corp V:LAB	Canada	CA$242.55K
DarkIris Inc. Class A Ordinary Shares NASDAQ:DKI	USA	$1.66 Million
Renoworks Software Inc V:RW	Canada	CA$2.31 Million
GCP Infrastructure Investments Limited LSE:GCP	UK	GBX22.42 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Alzinova AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Alzinova AB.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alzinova AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alzinova AB (2012–2025)

The table below shows the annual total liabilities of Alzinova AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr21.47 Million ≈ $2.31 Million	+128.33%
2024-12-31	Skr9.40 Million ≈ $1.01 Million	+0.77%
2023-12-31	Skr9.33 Million ≈ $1.00 Million	+53.27%
2022-12-31	Skr6.09 Million ≈ $655.15K	+89.09%
2021-12-31	Skr3.22 Million ≈ $346.48K	-32.81%
2020-12-31	Skr4.79 Million ≈ $515.68K	+8.40%
2019-12-31	Skr4.42 Million ≈ $475.71K	+89.33%
2018-12-31	Skr2.33 Million ≈ $251.26K	+0.26%
2017-12-31	Skr2.33 Million ≈ $250.60K	+64.85%
2016-12-31	Skr1.41 Million ≈ $152.02K	-9.79%
2015-12-31	Skr1.57 Million ≈ $168.51K	+165.74%
2014-12-31	Skr589.25K ≈ $63.41K	-19.06%
2013-12-31	Skr728.02K ≈ $78.35K	+328.80%
2012-12-31	Skr169.78K ≈ $18.27K	--

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$8.00 Million

Skr74.30 Million SEK

Market Cap Rank

#27570 Global

#612 in Sweden

Share Price

Skr0.48

Change (1 day)

-0.10%

52-Week Range

Skr0.40 - Skr2.03

All Time High

Skr26.90